Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 139.00 | 121.25 | 1.1464 | 1.8325 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 110.00 | 121.25 | 0.9072 | 0.5607 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 92.36 | 122.00 | 121.25 | 1.0062 | 1.0317 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 156.25 | 92.36 | 108.00 | 121.25 | 0.8907 | 0.4894 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 92.36 | 100.00 | 121.25 | 0.8247 | 0.2243 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 132.00 | 121.25 | 1.0887 | 1.4831 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 92.36 | 192.00 | 121.25 | 1.5835 | 5.4491 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 156.25 | 92.36 | 130.00 | 121.25 | 1.0722 | 1.3884 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 92.36 | 164.00 | 121.25 | 1.3526 | 3.3164 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 196.00 | 121.25 | 1.6165 | 5.7969 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 156.25 | 92.36 | 89.00 | 121.25 | 0.7340 | -0.0902 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 156.25 | 92.36 | 125.00 | 121.25 | 1.0309 | 1.1613 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 128.00 | 121.25 | 1.0557 | 1.2959 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 99.00 | 121.25 | 0.8165 | 0.1933 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 156.25 | 92.36 | 139.00 | 121.25 | 1.1464 | 1.8325 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 163.00 | 121.25 | 1.3443 | 3.2497 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 110.00 | 121.25 | 0.9072 | 0.5607 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 156.25 | 92.36 | 99.00 | 121.25 | 0.8165 | 0.1933 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 92.36 | 140.00 | 121.25 | 1.1546 | 1.8847 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 77.00 | 121.25 | 0.6351 | -0.3709 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 92.36 | 68.00 | 121.25 | 0.5608 | -0.5416 |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 102.00 | 121.25 | 0.8412 | 0.2876 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 90.00 | 121.25 | 0.7423 | -0.0639 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 156.25 | 92.36 | 97.00 | 121.25 | 0.8000 | 0.1329 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 158.00 | 121.25 | 1.3031 | 2.9255 |